Youdinghuan Chen

7PUBLICATIONS
12CO-AUTHORS
Cancer geneticsGene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markersNeural networksReaction engineering (excl. nuclear reactions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 06, 2025
Reply to: "Comments on the paper 'Extensive epigenomic dysregulation is a hallmark of homologous recombination deficiency in triple-negative breast cancer' by Y. Chen et al."

Youdinghuan Chen, Lucas A Salas, Jonathan D Marotti

|Dec 05, 2024
Extensive epigenomic dysregulation is a hallmark of homologous recombination deficiency in triple-negative breast cancer.

Youdinghuan Chen, Lucas A Salas, Jonathan D Marotti

|Feb 01, 2023
Transcriptomic Profiling of Subcutaneous Adipose Tissue in Relation to Bariatric Surgery: A Retrospective, Pooled Re-analysis.

Youdinghuan Chen

|Sep 20, 2021
DNA 5-hydroxymethylcytosine in pediatric central nervous system tumors may impact tumor classification and is a positive prognostic marker.

Nasim Azizgolshani, Curtis L Petersen, Youdinghuan Chen

|Aug 21, 2021
MethylSPWNet and MethylCapsNet: Biologically Motivated Organization of DNAm Neural Networks, Inspired by Capsule Networks.

Joshua J Levy, Youdinghuan Chen, Nasim Azizgolshani

|Jul 05, 2020
Silencing hepatic MCJ attenuates non-alcoholic fatty liver disease (NAFLD) by increasing mitochondrial fatty acid oxidation.

Lucía Barbier-Torres, Karen A Fortner, Paula Iruzubieta

Pageof 2

Frequent Collaborators

3 joint publications

Brock C Christensen

2 joint publications

Curtis L Petersen

2 joint publications

Lucas A Salas

2 joint publications

Chao Cheng